NEW YORK (GenomeWeb News) – Pressure BioSciences on Tuesday reported that revenues for full-year 2012 increased 21 percent year over year, but warned that it may not have enough cash to last through the month.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.
At Nature, John Wilbanks and Eric Topol call for openness in health data.
Law.com predicts that genomic and genetic testing will become common in toxic tort cases.
A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.